Jopamiro

Iopamidol, the active ingredient in Jopamiro, is an iodinated contrast media presented as a sterile injectable solution for intra‑articular, intrathecal, and intravenous use. It enhances X‑ray attenuation, thereby improving the visibility of anatomical structures during diagnostic and interventional imaging procedures in patients of all ages.

GNH USA supplies Jopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic imaging centres, and clinics worldwide, ensuring consistent quality and regulatory compliance across markets, with a focus on timely delivery and support for procurement teams.

Iopamidol is employed as an iodinated contrast agent to improve radiographic visualization across several imaging modalities.

- Computed Tomography (CT): enhances differentiation of soft‑tissue, vascular, and organ structures during CT scans. - Angiography: increases contrast of blood vessels, aiding diagnosis and therapeutic planning in arterial and venous studies. - Myelography: provides clear delineation of the spinal canal and nerve roots for diagnostic evaluation of the central nervous system.

Iopamidol may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Warm sensation at injection site - Nausea - Headache - Metallic taste - Transient flushing - Mild hypotension

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Contrast‑induced nephropathy - Cardiac arrhythmia - Pulmonary edema - Severe hypotension or shock

Prior to administration, several safety considerations should be observed.

- Assess renal function: evaluate serum creatinine before use in patients with kidney disease. - Screen for iodine allergy: obtain a detailed history of hypersensitivity to iodinated contrast. - Hydration: ensure adequate fluid intake before and after the procedure to reduce nephrotoxicity risk. - Avoid in uncontrolled hyperthyroidism: iodine load may exacerbate thyroid hormone release. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Store at ambient temperature: keep below 25 °C, protect from light and moisture in the original packaging.

Iopamidol can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Concurrent use of high‑dose nephrotoxic agents (e.g., aminoglycosides, NSAIDs): increased risk of renal injury. - Combination with metformin in patients with impaired renal function: risk of lactic acidosis; discontinue metformin before and after administration. - Co‑administration with iodinated thyroid medications: may cause excessive iodine load.

Moderate Interactions (Monitor Closely): - Use with beta‑blockers: may mask signs of contrast reaction. - Concurrent diuretics: may affect fluid balance, monitor renal function. - Administration with other contrast agents: cumulative iodine exposure should be evaluated.